Skip to main content
OpenTrials

Clinical trial condition

Adenocarcinoma

Explore clinical trials studying Adenocarcinoma. Study availability and eligibility vary by location and protocol.

5,098 public trials 1,201 recruiting studies
Refine in advanced search Browse all conditions

Adenocarcinoma trial results

Recruiting

A Study to Evaluate Patient-Reported Satisfaction, Effectiveness, and Safety of Atezolizumab in Participants Treated in Routine Clinical Practice

NCT07284121

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +14 more
Locations
  • Landesklinikum Krems Krems, Austria
  • Ordensklinikum Linz Elisabethinen Linz, Austria
  • Krankenhaus Nord - Klinik Floridsdorf Vienna, Austria
  • Klinikum Wels-Grieskirchen Wels, Austria
View all 92 locations
View Trial Details
Recruiting

A Clinical Study of Belzutifan (MK-6482) and Zanzalintinib in People With Renal Cell Carcinoma (RCC) (LITESPARK-034/LS-034/MK-6482-034)

NCT07489495

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +13 more
Locations
  • Northwest Georgia Oncology Centers, a Service of Wellstar Cobb Hospital ( Site 0102) Marietta, Georgia, United States
  • The West Clinic, P.C. ( Site 0115) Germantown, Tennessee, United States
  • Centro Oncologico Korben ( Site 0254) CABA, Buenos Aires, Argentina
  • Hospital Italiano de Buenos Aires ( Site 0253) Ciudad de Buenos Aires, Buenos Aires, Argentina
View all 89 locations
View Trial Details
Recruiting

REGN15505 (PSMAx4-1BB) Alone or in Combination With Cemiplimab or REGN4336 (PSMAxCD3) in Adult Patients With Metastatic Castration-Resistant Prostate Cancer and Clear Cell Renal Cell Carcinoma

NCT07594106

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +15 more
Locations
  • City of Hope Phoenix Goodyear, Arizona, United States
  • City of Hope Duarte, California, United States
  • City of Hope Chicago, City of Hope Cancer Center Chicago Zion, Illinois, United States
  • The University of Texas MD Anderson Cancer Center Houston, Texas, United States
View Trial Details
Recruiting

Breath Research Narrow Validation for Gastrointestinal Cancer Detection

NCT07714538

Conditions
Adenocarcinoma, Adenocarcinoma Of Esophagus, Carcinoma, +35 more
Locations
  • Maidstone and Tunbridge Wells NHS Trust Maidstone, Kent, United Kingdom
  • Liverpool University Hospitals NHS Foundation Trust Liverpool, Merseyside, United Kingdom
  • NHS Greater Glasgow and Clyde Glasgow, United Kingdom
  • The Clatterbridge Cancer Centre NHS Foundation Trust Liverpool, United Kingdom
View Trial Details
Recruiting

Real-world Evaluation of the HistoSonics Edison System for Treatment of Liver Tumors Across Multidisciplinary Users (BOOMBOX: Master Study)

NCT06486454

Conditions
Adenocarcinoma, Benign Liver Tumor, Carcinoma, +12 more
Locations
  • Providence St. Jude Fullerton, California, United States
  • Mission Hospital Mission Viejo, California, United States
  • Hoag Newport Beach, California, United States
  • Sutter Bay Hospitals San Francisco, California, United States
View all 33 locations
View Trial Details
Recruiting

GPC3-Targeted T-Cell Therapy (ECT204) in Adults With Advanced HCC

NCT04864054

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +12 more
Locations
  • City of Hope Duarte, California, United States
  • Kansas University Medical Center, Principal Investigator: Westwood, Kansas, United States
  • Roswell Park Comprehensive Cancer Center Buffalo, New York, United States
  • Montefiore Einstein Comprehensive Cancer Center The Bronx, New York, United States
View Trial Details
Recruiting

Preoperative Evaluation of Lymph Nodes of Cholangiocarcinoma (POELH-III)

NCT07161869

Conditions
Adenocarcinoma, Adenocarcinoma of Biliary Tract, Bile Duct Diseases, +18 more
Locations
  • Erasmus MC University Medical Center Rotterdam, South Holland, Netherlands
  • Amsterdam University Medical Center Amsterdam, Netherlands
  • University Medical Center Groningen Groningen, Netherlands
  • Leiden University Medical Center Leiden, Netherlands
View Trial Details
Recruiting

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

NCT03866382

Conditions
Adenocarcinoma, Bladder Adenocarcinoma, Bladder Clear Cell Adenocarcinoma, +71 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
View all 581 locations
View Trial Details

Related conditions